Ethan Paddock1, Helen C Looker1, Paolo Piaggi1, William C Knowler1, Jonathan Krakoff1, Douglas C Chang2. 1. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ. 2. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ changdc@mail.nih.gov.
Abstract
OBJECTIVE: We compared the ability of 1- and 2-h plasma glucose concentrations (1h-PG and 2h-PG, respectively), derived from a 75-g oral glucose tolerance test (OGTT), to predict retinopathy. 1h-PG and 2h-PG concentrations, measured in a longitudinal study of an American Indian community in the southwestern U.S., a population at high risk for type 2 diabetes, were analyzed to assess the usefulness of the 1h-PG to identify risk of diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: Cross-sectional (n = 2,895) and longitudinal (n = 1,703) cohorts were assessed for the prevalence and incidence of DR, respectively, in relation to deciles of 1h-PG and 2h-PG concentrations. Areas under the receiver operating characteristic (ROC) curves for 1h-PG and 2h-PG were compared with regard to predicting DR, as assessed by direct ophthalmoscopy. RESULTS: Prevalence and incidence of DR, based on direct ophthalmoscopy, changed in a similar manner across the distributions of 1h-PG and 2h-PG concentrations. ROC analysis showed that 1h-PG and 2h-PG were of similar value in identifying prevalent and incident DR using direct ophthalmoscopy. 1h-PG cut points of 230 and 173 mg/dL were comparable to 2h-PG cut points of 200 mg/dL (type 2 diabetes) and 140 mg/dL (impaired glucose tolerance), respectively. CONCLUSIONS: 1h-PG is a useful predictor of retinopathy risk, has a predictive value similar to that of 2h-PG, and may be considered as an alternative glucose time point during an OGTT.
OBJECTIVE: We compared the ability of 1- and 2-h plasma glucose concentrations (1h-PG and 2h-PG, respectively), derived from a 75-g oral glucose tolerance test (OGTT), to predict retinopathy. 1h-PG and 2h-PG concentrations, measured in a longitudinal study of an American Indian community in the southwestern U.S., a population at high risk for type 2 diabetes, were analyzed to assess the usefulness of the 1h-PG to identify risk of diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: Cross-sectional (n = 2,895) and longitudinal (n = 1,703) cohorts were assessed for the prevalence and incidence of DR, respectively, in relation to deciles of 1h-PG and 2h-PG concentrations. Areas under the receiver operating characteristic (ROC) curves for 1h-PG and 2h-PG were compared with regard to predicting DR, as assessed by direct ophthalmoscopy. RESULTS: Prevalence and incidence of DR, based on direct ophthalmoscopy, changed in a similar manner across the distributions of 1h-PG and 2h-PG concentrations. ROC analysis showed that 1h-PG and 2h-PG were of similar value in identifying prevalent and incident DR using direct ophthalmoscopy. 1h-PG cut points of 230 and 173 mg/dL were comparable to 2h-PG cut points of 200 mg/dL (type 2 diabetes) and 140 mg/dL (impaired glucose tolerance), respectively. CONCLUSIONS:1h-PG is a useful predictor of retinopathy risk, has a predictive value similar to that of 2h-PG, and may be considered as an alternative glucose time point during an OGTT.
Authors: Manan Pareek; Deepak L Bhatt; Mette L Nielsen; Ram Jagannathan; Karl-Fredrik Eriksson; Peter M Nilsson; Michael Bergman; Michael H Olsen Journal: Diabetes Care Date: 2017-11-14 Impact factor: 19.112
Authors: Akram Alyass; Peter Almgren; Mikael Akerlund; Jonathan Dushoff; Bo Isomaa; Peter Nilsson; Tiinamaija Tuomi; Valeriya Lyssenko; Leif Groop; David Meyre Journal: Diabetologia Date: 2014-10-08 Impact factor: 10.122
Authors: Helen C Looker; Jonathan Krakoff; William C Knowler; Peter H Bennett; Ronald Klein; Robert L Hanson Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: Pavithra Vijayakumar; Robert G Nelson; Robert L Hanson; William C Knowler; Madhumita Sinha Journal: Diabetes Care Date: 2016-11-03 Impact factor: 19.112
Authors: Kannan Kasturi; Anthony U Onuzuruike; Shwetha Kunnam; Lauren B Shomaker; Jack A Yanovski; Stephanie T Chung Journal: Pediatr Diabetes Date: 2018-12-27 Impact factor: 4.866
Authors: Vanessa Guerreiro; Isabel Maia; João Sérgio Neves; Daniela Salazar; Maria João Ferreira; Fernando Mendonça; Maria Manuel Silva; Marta Borges-Canha; Sara Viana; Cláudia Costa; Jorge Pedro; Ana Varela; Eva Lau; Paula Freitas; Davide Carvalho Journal: Diabetol Metab Syndr Date: 2022-07-06 Impact factor: 5.395
Authors: Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert Journal: Diabetes Res Clin Pract Date: 2020-06-01 Impact factor: 5.602
Authors: Vasudha Ahuja; Pasi Aronen; T A Pramodkumar; Helen Looker; Angela Chetrit; Aini H Bloigu; Auni Juutilainen; Cristina Bianchi; Lucia La Sala; Ranjit Mohan Anjana; Rajendra Pradeepa; Ulagamadesan Venkatesan; Sarvanan Jebarani; Viswanathan Baskar; Teresa Vanessa Fiorentino; Patrick Timpel; Ralph A DeFronzo; Antonio Ceriello; Stefano Del Prato; Muhammad Abdul-Ghani; Sirkka Keinänen-Kiukaanniemi; Rachel Dankner; Peter H Bennett; William C Knowler; Peter Schwarz; Giorgio Sesti; Rie Oka; Viswanathan Mohan; Leif Groop; Jaakko Tuomilehto; Samuli Ripatti; Michael Bergman; Tiinamaija Tuomi Journal: Diabetes Care Date: 2021-04 Impact factor: 19.112
Authors: Anni Saunajoki; Juha Auvinen; Aini Bloigu; Jouko Saramies; Jaakko Tuomilehto; Hannu Uusitalo; Esko Hussi; Henna Cederberg-Tamminen; Kadri Suija; Sirkka Keinänen-Kiukaanniemi; Markku Timonen Journal: J Clin Med Date: 2022-07-15 Impact factor: 4.964
Authors: Anni Saunajoki; Juha Auvinen; Ville Saarela; Janne-Joonas Uusitalo; Ilmari Leiviskä; Sirkka Keinänen-Kiukaanniemi; M Johanna Liinamaa; Markku Timonen Journal: PLoS One Date: 2020-10-22 Impact factor: 3.240